MORGAN COULTER: Open Payments
NPI 1154884286 · ELKMONT, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$510 in 23 payments from 10 companies in 2025. Trend: 2023 $98 · 2024 $141 · 2025 $510
Food & beverage: $510
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $123 |
| ABBVIE INC. | 4 | $110 |
| Novo Nordisk Inc | 5 | $97 |
| AstraZeneca Pharmaceuticals LP | 3 | $63 |
| Antares Pharma, Inc. | 1 | $28 |
| Abbott Laboratories | 1 | $23 |
| PFIZER INC. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Philips North America LLC | 1 | $14 |
Products named: CAPLYTA, VRAYLAR, Wegovy, AIRSUPRA, XYOSTED, FREESTYLE LIBRE 3, Ozempic, BREZTRI.
Industry payments across AL — which companies pay providers there.
